Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Multiple-Dose Safety & Efficacy Study of A Selective Inhibito-261975021
University of Texas MD Anderson Cancer Center
Search grants from University of Texas MD Anderson Cancer Center
Share this grant:
:
:
Abstract
Funding
Institution
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Substructural Volumetry of Hippocampus and Thalamus in Alcoholism
Inflammatory Bowel Disease-Associated Malignant Transformation
Broad Neutralization of HIV-1 from Rhinoviruses Displaying gp41 MPER Sequences
Preclinical Studies of PET Radiopharmaceuticals
Opioid Peptides-Receptor Ion Channel Coupling
Recently added grants:
Chelator development for improved scandium theranostic agents
eIF2A in translational control
Theoretical Modeling of the Vibrational Spectroscopy of Nucleic Acids
Protein Domain Mimics as Modulators of Biomolecular Interactions
Redox Regulation of Cysteine-Dependent Peroxidases and Signal Transduction Pathways
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA075021-005
Application #
6688635
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2002
Total Cost
Indirect Cost
Institution
Name
University of Texas MD Anderson Cancer Center
Department
Type
DUNS #
City
State
Country
Zip Code
Comments
Be the first to comment on this grant